Skip to main content

Market Overview

UPDATE: Morgan Stanley Reiterates On Varian Medical Systems On Mid-Year Updates

Share:

In a report published Wednesday, Morgan Stanley analyst Steve Beuchaw reiterated an Underweight rating on Varian Medical Systems (NYSE: VAR), but removed the $76.00 price target.

In the report, Morgan Stanley noted, “Financial takeaways in line with our expectations; Oncology revenue still the key variable. Varian is confident in EBIT margin expansion, consistent with our expectations, and continues to expect revenue in Oncology +5-8%, Imaging +10-12%, and at $200-300mn peak in Proton. Our estimates remain more conservative in Oncology given ongoing backlog deceleration and our expectation for tougher US reimbursement.

"While gross orders have been encouraging, recent strength is in part a reflection of a larger proportion of multi-year orders and more frequent service contract advance bookings.”

Varian Medical Systems closed on Tuesday at $80.86.

Latest Ratings for VAR

DateFirmActionFromTo
Dec 2020JefferiesDowngradesBuyHold
Oct 2020BairdDowngradesOutperformNeutral
Aug 2020BTIGDowngradesBuyNeutral

View More Analyst Ratings for VAR
View the Latest Analyst Ratings

 

Related Articles (VAR)

View Comments and Join the Discussion!

Posted-In: Morgan Stanley Steve BeuchawAnalyst Color Price Target Analyst Ratings

Latest Ratings

StockFirmActionPT
GIKColliers SecuritiesInitiates Coverage On14.0
SANWLake StreetInitiates Coverage On6.0
LILAMorgan StanleyDowngrades15.0
BEJP MorganUpgrades36.0
NEXACredit SuisseUpgrades11.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com